Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05124886 · ClinicalTrials.gov registry record · NA
Gut Kidney Axis in Enteric Hyperoxaluria
A NA study of Enteric Hyperoxaluria, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05124886 is a NA study of Enteric Hyperoxaluria that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05124886, a NA study of Enteric Hyperoxaluria, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
40 subjects with a confirmed diagnosis of IBD or \>6 months post-RYGB with a diagnosed USD event or kidney stone on imaging within the past three years and 40 healthy controls will be administered a high oxalate diet on Days 0-3 and Days 21-24 with a washout period on Days 4-7 and will be administered 250mg sodium oxalate on Days 8-20, via prepared spinach, from Weil Cornell Medicine's Clinical and Translational Science Center. Subjects will partake in four stool collections, four 24-h urine collections, two blood collections, and four sets of colonic permeability testing.
Conditions Studied
Interventions
- OTHER Moderately High Oxalate (MOx) Diet
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05124886
The ClinicalTrials.gov registry entry for NCT05124886 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Enteric Hyperoxaluria appearing as the primary indexed condition, and to 1 intervention - of which Moderately High Oxalate (MOx) Diet is the first listed.
NCT05124886 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05124886 about?
NCT05124886 is a clinical study titled "Gut Kidney Axis in Enteric Hyperoxaluria". 40 subjects with a confirmed diagnosis of IBD or \>6 months post-RYGB with a diagnosed USD event or kidney stone on imaging within the past three years and 40 healthy controls will be administered a high oxalate diet on Days 0-3 and Days 21-24 with a washout period on Days 4-7 and will be administer...
What is the current status of trial NCT05124886?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-11-10. Estimated completion is 2026-03-01.
What conditions does trial NCT05124886 study?
This clinical trial studies the following conditions: Enteric Hyperoxaluria.
What interventions are being tested in trial NCT05124886?
The interventions under investigation include: Moderately High Oxalate (MOx) Diet (OTHER).
Who is sponsoring clinical trial NCT05124886?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05124886 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enteric Hyperoxaluria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.